Scope devices that are difficult to clean have been called out in certain cases for causing antibiotic-resistant infections in the past. Olympus, a Japan-based device maker, failed to report infection investigations to the FDA or American hospitals, and they are now being called out.
The threat of superbugs is a real concern. For that reason, the FDA is providing new regulations concerning the use of antibiotics in animals we eat.
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
By Kurt R. Karst – On December 12th, a group of bipartisan lawmakers led by Representatives Phil Gingrey (R-GA) and Gene Green (D-TX) introduced the Antibiotic Development to Advance Patient Treatment Act of 2013 (“ADAPT Act”). If enacted, the ADAPT...
athenahealth’s January acquisition of mobile health company Epocrates has generated its first market-ready byproduct, as the two brands today announced a joint mobile app called “Bugs + Drugs.” The app for physicians pairs Epocrates’ mobile mastery and clinical content with data from the more than 40 million medical records athenahealth (NASDAQ:ATHN) hosts in the cloud. […]